Dec 17 (Reuters) - Genetic Signatures Ltd (GSS) :
- RECEIVED CE-IVD REGISTRATION PERMITTING SALE OF ITS EASYSCREENTM RESPIRATORY PATHOGEN DETECTION KIT IN EUROPE
- SIMULTANEOUSLY, CO HAS BEEN PROGRESSING MARKET ENTRY OF EASYSCREENTM RESPIRATORY PATHOGEN DETECTION KIT IN AUSTRALIA
News: GSS Genetic Signatures Received CE-IVD Mark For Respiratory Pathogen Detection Kit In Europe
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
-0.020(4.76%) |
Mkt cap ! $90.85M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.0¢ | 40.0¢ | $37.41K | 92.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 2201 | 1 |
View Market Depth
| Last trade - 15.18pm 22/07/2025 (20 minute delay) ? |
| GSS (ASX) Chart |